dalteparin has been researched along with Exophthalmos in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Exophthalmos: Abnormal protrusion of both eyes; may be caused by endocrine gland malfunction, malignancy, injury, or paralysis of the extrinsic muscles of the eye.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mansurali, N | 1 |
| Maclaren, G | 1 |
| Sundar, G | 1 |
| Dey, M | 1 |
| Charles Bates, A | 1 |
| McMillan, P | 1 |
2 other studies available for dalteparin and Exophthalmos
| Article | Year |
|---|---|
Bilateral orbital haematomas in an anticoagulated patient with severe H1N1 influenza.
Topics: Anticoagulants; Enoxaparin; Exophthalmos; Female; Functional Laterality; Humans; Influenza A Virus, | 2011 |
Superior ophthalmic vein thrombosis as an initial manifestation of antiphospholipid syndrome.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Dalteparin; Drug Therapy, Combination; Exophthalmo | 2013 |